Skip to main content

Advertisement

Log in

Primary Immunodeficiency Diseases: A 30-year Patient Registry from the Referral Center for Primary Immunodeficiencies in Greece

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Primary Immunodeficiencies (PID) represent a group of heterogeneous immune diseases with important biological significance. We reviewed the records of children diagnosed with PID in the Referral Center for PID in our country in order to describe the epidemiological, clinical and laboratory characteristics of immunodeficient patients. During a 30-year period, 147 patients (101 males, 68.7 %), with a mean age of 6.5 years at the time of diagnosis, were diagnosed with PID. The most prevalent diagnoses of PID were: “Combined Immunodeficiency” in 46 (31.3 %) patients, “Well-defined immunodeficiency syndrome” in 35 (23.1 %) patients, “Predominantly antibody deficiency” in 30 (20.4 %) patients and “Congenital defect of phagocyte function or both” in 28 (19 %) patients. There was a higher prevalence of males with “Combined immunodeficiency” (p < 0.033) and “Predominantly antibody deficiency” (p < 0.02) compared to females. The median age of children at the onset of symptoms and at the time of diagnosis was 0.5y (IQR: 0.1–2.5) and 2y (IQR: 0.6–7.2), respectively. The median diagnostic delay was 0.9y (IQR: 0.2–4.8). This period was shorter for patients with “Combined immunodeficiency” [median 0.3y (IQR: 0.1–1)], and longer for those with “Predominantly antibody deficiency” [median 3.2y (IQR: 0.2–5.9) or “Disease of immune dysregulation” [median 3.2y (IQR: 0.1–6.6)]. Comparing the rates in our population with those of the European Registry (ESID), the rates of “Combined immunodeficiencies”, “Well-defined syndromes” and “Congenital birth defects and/or function of phagocytes” were significantly higher in this study (p <0,001). PID registry analysis improves knowledge in the field of Immunology and enhances awareness, early detection, diagnosis, and management of this rare but significant group of diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ALPS:

Autoimmune Lymphoproliferative Syndrome

APECED:

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy

CGD:

Chronic Granulomatous Disease

CVID:

Common Variable Immunodeficiency

ESID:

European Society for Immunodeficiencies

HIES:

Hyper IgE Syndrome

IFN-γR1:

Interferon-γ Receptor 1

IUIS:

International Union of Immunological Societies

MHC:

Major Histocompatibility Complex

NOMID:

Neonatal Onset Multisystem Inflammatory Disease

CINCA:

Chronic Infantile Neurological Cutaneous Articular

PID/PIDs:

Primary Immunodeficiencies

SCID:

Severe combined immunodeficiency

WAS:

Wiskott-Aldrich Syndrome

XHIMS:

X-linked Hyper-IgM Syndrome

XLA:

X-linked agammaglobulinemia

References

  1. Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(5):S1–63.

    Article  PubMed  Google Scholar 

  2. de Vries E. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167(1):108–19.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cassimos DC, Liatsis M, Stogiannidou A, Kanariou MG. Children with frequent infections: a proposal for a stepwise assessment and investigation of the immune system. Pediatr Allergy Immunol. 2010;21(3):463–73.

    Article  PubMed  Google Scholar 

  4. Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. J Allergy Clin Immunol. 2009;124(6):1152–60. e12.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Chapel H. Classification of primary immunodeficiency diseases by the international union of immunological societies (IUIS) expert committee on primary immunodeficiency 2011. Clin Exp Immunol. 2012;168(1):58–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sanal O, Tezcan I. Thirty years of primary immunodeficiencies in Turkey. Ann N Y Acad Sci. 2011;1238:15–23.

    Article  PubMed  Google Scholar 

  8. Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)–diagnosis, treatment, and economic impact: an updated report from the Jeffrey modell foundation. Immunol Res. 2011;51(1):61–70.

    Article  PubMed  Google Scholar 

  9. Matamoros Flori N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan CG. Primary immunodeficiency syndrome in Spain: first report of the national registry in children and adults. J Clin Immunol. 1997;17(4):333–9.

    Article  PubMed  CAS  Google Scholar 

  10. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL et al. Primary Immunodeficiency Diseases Worldwide: More Common than Generally Thought. Journal of clinical immunology. 2012.

  11. Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497–502.

    Article  PubMed  CAS  Google Scholar 

  13. Golan H, Dalal I, Garty BZ, Schlesinger M, Levy J, Handzel Z, et al. The incidence of primary immunodeficiency syndromes in Israel. The Israel Medical Association journal : IMAJ. 2002;4(11):868–71.

    PubMed  Google Scholar 

  14. group CTFPs. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135(2):264–72.

    Article  Google Scholar 

  15. Gathmann B, Binder N, Ehl S, Kindle G. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167(3):479–91.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Samarghitean C, Valiaho J, Vihinen M. Online registry of genetic and clinical immunodeficiency diagnostic laboratories, IDdiagnostics. J Clin Immunol. 2004;24(1):53–61.

    Article  PubMed  Google Scholar 

  17. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078–87.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American group for immunodeficiency) and ESID (European society for immunodeficiencies). Clin Immunol. 1999;93(3):190–7.

    Article  PubMed  CAS  Google Scholar 

  19. Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29(3):343–51.

    Article  PubMed  Google Scholar 

  20. Kilic S, Ozel M, Hafizoglu D, Karaca N, Aksu G, Kutukculer N. The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey–two centers study. J Clin Immunol. 2013;33(1):74–83.

    Article  PubMed  CAS  Google Scholar 

  21. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait national primary Immunodeficiency Registry (2004–2006). J Clin Immunol. 2008;28(2):186–93.

    Article  PubMed  Google Scholar 

  22. Michos A, Tzanoudaki M, Villa A, Giliani S, Chrousos G, Kanariou M. Severe combined immunodeficiency in Greek children over a 20-year period: rarity of gammac-chain deficiency (X-linked) type. J Clin Immunol. 2011;31(5):778–83.

    Article  PubMed  Google Scholar 

  23. Raptaki MV, Spanou I, Tzanoudaki K, Tantou M, Liatsis S, Constantinidou M, et al. A 25-year Patient Registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece journal of clinical immunology. J Clin Immunol. 2013;33(8):1302–9.

    Article  PubMed  Google Scholar 

  24. Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 1997;130(3):378–87.

    Article  PubMed  CAS  Google Scholar 

  25. Yee A, De Ravin SS, Elliott E, Ziegler JB. Severe combined immunodeficiency: a national surveillance study. Pediatr Allergy Immunol. 2008;19(4):298–302.

    Article  PubMed  Google Scholar 

  26. Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clinic proceedings Mayo Clinic. 2009;84(1):16–22.

    Article  Google Scholar 

  27. Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the republic of Ireland: first report of the national registry in children and adults. J Clin Immunol. 2005;25(1):73–7.

    Article  PubMed  CAS  Google Scholar 

  28. Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20(6):477–85.

    Article  PubMed  CAS  Google Scholar 

  29. Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007;147(2):306–12.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77–85.

    Article  PubMed  CAS  Google Scholar 

  31. Casanova JL, Fieschi C, Zhang SY, Abel L. Revisiting human primary immunodeficiencies. J Intern Med. 2008;264(2):115–27.

    Article  PubMed  CAS  Google Scholar 

  32. Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295(5):508–18.

    Article  PubMed  CAS  Google Scholar 

  33. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Gene therapy of primary T cell immunodeficiencies. Gene. 2013;525(2):170–3.

    Article  PubMed  CAS  Google Scholar 

  34. Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014;383(9915):436–48.

    Article  PubMed  CAS  Google Scholar 

  35. Mukherjee S, Thrasher AJ. Gene therapy for PIDs: progress, pitfalls and prospects. Gene. 2013;525(2):174–81.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgments

We acknowledge Alessandro Aiuti, Francisco Antonio Bonilla, Jean-Laurent Casanova, Graham Davies, Anne Durandy, Stephan Ehl, Teresa Espanol, Alain Fischer, Wilhelm Friedrich, Raif Geha, Silvia Giliani, Kimberly Gilmour, Bodo Grimbacher, Lennart Hammastom, Haifa Jabara, Alison Jones, Christine Kinnon, Anastasia Kondyli, Francoise Le Deist, Katy Mandalenaki, John Manis, M. Louise Markert, Gareth Morgan, Luigi Notarangelo, Hans Ochs, Gabriel Pantelias, Capucine Picard, Frederic Rieux-Laucat, Costas Ritis, Genevieve de Saint Basile, Fabian Schumacher, Klaus Schwarz, Antony Segal, Reinhart Seger, Edvard Smith, Christina Sobachi, Stephan Strobel, Anna Villa, Jean-Pierre de Villartay, Effie Vrachnou, David Webster, colleagues at “Aghia Sophia” and “P & A Kyriakou” Children’s Hospitals for their collaboration in many cases and for their contribution in diagnosis and/or management of certain patients, Paediatricians and Physicians from other Hospitals in Greece for referring their patients to us, as well as, nurses and technicians in our Department. We also thank 1st Health Region of Attica for supporting part of this project, Ms Penny Kassari for organizing part of this work, Mr Panos Liverakos for his encouragement, the Greek Lottery Company (Organismos Prognostikon Agonon Podosfairou - OPAP S.A) and the former President of the Board C. Hatjiemmanuil for a grant which was used for the genetic diagnosis and registry of a significant number of patients. Thanks to R. Halls for his support for the manuscript and special thanks to Mrs Pitsa Kalamotousis for her support for this project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Kanariou.

Additional information

Athanasios Michos and Maria Raptaki are contributed equally

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Michos, A., Raptaki, M., Tantou, S. et al. Primary Immunodeficiency Diseases: A 30-year Patient Registry from the Referral Center for Primary Immunodeficiencies in Greece. J Clin Immunol 34, 836–843 (2014). https://doi.org/10.1007/s10875-014-0066-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-014-0066-8

Keywords

Navigation